These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 24580391)

  • 1. Glycaemic control and long-term outcomes following transition from modified intensive insulin therapy to conventional glycaemic control.
    Orford NR; Bailey M; Kaukonen K; Elderkin T; Stow P; Cattigan C; Kotowicz M; Bellomo R
    Anaesth Intensive Care; 2014 Mar; 42(2):239-47. PubMed ID: 24580391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycaemic control in Australia and New Zealand before and after the NICE-SUGAR trial: a translational study.
    Kaukonen KM; Bailey M; Pilcher D; Orford N; Finfer S; Bellomo R
    Crit Care; 2013 Oct; 17(5):R215. PubMed ID: 24088368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycaemic fluctuation predicts mortality in critically ill patients.
    Al-Dorzi HM; Tamim HM; Arabi YM
    Anaesth Intensive Care; 2010 Jul; 38(4):695-702. PubMed ID: 20715734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tight glycaemic control: a prospective observational study of a computerised decision-supported intensive insulin therapy protocol.
    Shulman R; Finney SJ; O'Sullivan C; Glynne PA; Greene R
    Crit Care; 2007; 11(4):R75. PubMed ID: 17623086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of diabetes mellitus on the association between measures of glycaemic control and ICU mortality: a retrospective cohort study.
    Sechterberger MK; Bosman RJ; Oudemans-van Straaten HM; Siegelaar SE; Hermanides J; Hoekstra JB; De Vries JH
    Crit Care; 2013 Mar; 17(2):R52. PubMed ID: 23510051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus.
    Hemmingsen B; Lund SS; Gluud C; Vaag A; Almdal TP; Hemmingsen C; Wetterslev J
    Cochrane Database Syst Rev; 2013 Nov; (11):CD008143. PubMed ID: 24214280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perioperative glycaemic control for diabetic patients undergoing surgery.
    Buchleitner AM; Martínez-Alonso M; Hernández M; Solà I; Mauricio D
    Cochrane Database Syst Rev; 2012 Sep; (9):CD007315. PubMed ID: 22972106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial.
    Russell SJ; Hillard MA; Balliro C; Magyar KL; Selagamsetty R; Sinha M; Grennan K; Mondesir D; Ekhlaspour L; Zheng H; Damiano ER; El-Khatib FH
    Lancet Diabetes Endocrinol; 2016 Mar; 4(3):233-243. PubMed ID: 26850709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of intensive intraoperative glycaemic control in cardiopulmonary bypass surgery: a randomised trial.
    Rujirojindakul P; Liabsuetrakul T; McNeil E; Chanchayanon T; Wasinwong W; Oofuvong M; Rergkliang C; Chittithavorn V
    Acta Anaesthesiol Scand; 2014 May; 58(5):588-96. PubMed ID: 24628042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus.
    Hemmingsen B; Lund SS; Gluud C; Vaag A; Almdal T; Hemmingsen C; Wetterslev J
    Cochrane Database Syst Rev; 2011 Jun; (6):CD008143. PubMed ID: 21678374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of dysglycaemic events among inpatients with diabetes mellitus: a Singaporean perspective.
    Ong KY; Kwan YH; Tay HC; Tan DS; Chang JY
    Singapore Med J; 2015 Jul; 56(7):393-400. PubMed ID: 26243976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoglycaemia and predisposing factors among clinical subgroups treated with intensive insulin therapy.
    Waeschle RM; Bräuer A; Hilgers R; Herrmann P; Neumann P; Quintel M; Moerer O
    Acta Anaesthesiol Scand; 2014 Feb; 58(2):223-34. PubMed ID: 24372028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The usage of a simplified self-titration dosing guideline (303 Algorithm) for insulin detemir in patients with type 2 diabetes--results of the randomized, controlled PREDICTIVE 303 study.
    Meneghini L; Koenen C; Weng W; Selam JL
    Diabetes Obes Metab; 2007 Nov; 9(6):902-13. PubMed ID: 17924873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers related to severe hypoglycaemia and lack of good glycaemic control in ACCORD.
    Chow LS; Chen H; Miller ME; Marcovina SM; Seaquist ER
    Diabetologia; 2015 Jun; 58(6):1160-6. PubMed ID: 25652389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.
    Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R
    Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial.
    El-Khatib FH; Balliro C; Hillard MA; Magyar KL; Ekhlaspour L; Sinha M; Mondesir D; Esmaeili A; Hartigan C; Thompson MJ; Malkani S; Lock JP; Harlan DM; Clinton P; Frank E; Wilson DM; DeSalvo D; Norlander L; Ly T; Buckingham BA; Diner J; Dezube M; Young LA; Goley A; Kirkman MS; Buse JB; Zheng H; Selagamsetty RR; Damiano ER; Russell SJ
    Lancet; 2017 Jan; 389(10067):369-380. PubMed ID: 28007348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of an algorithm for intensive subcutaneous insulin therapy in noncritically ill hospitalised patients with hyperglycaemia in a randomised controlled trial.
    Thomann R; Schütz P; Müller B; Thomke S; Schoenenberger R; Keller U
    Swiss Med Wkly; 2013; 143():w13808. PubMed ID: 23771784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
    Wenying Y; Benroubi M; Borzi V; Gumprecht J; Kawamori R; Shaban J; Shah S; Shestakova M; Ligthelm R; Valensi P;
    Curr Med Res Opin; 2009 Nov; 25(11):2643-54. PubMed ID: 19751116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2).
    Zinman B; Marso SP; Poulter NR; Emerson SS; Pieber TR; Pratley RE; Lange M; Brown-Frandsen K; Moses A; Ocampo Francisco AM; Barner Lekdorf J; Kvist K; Buse JB;
    Diabetologia; 2018 Jan; 61(1):48-57. PubMed ID: 28913575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.